{"id":515333,"date":"2021-07-20T16:18:45","date_gmt":"2021-07-20T20:18:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/"},"modified":"2021-07-20T16:18:45","modified_gmt":"2021-07-20T20:18:45","slug":"jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/","title":{"rendered":"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">DUBLIN<\/span>, <span class=\"xn-chron\">July 20, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 second quarter financial results on <span class=\"xn-chron\">Tuesday, August 3, 2021<\/span> after the close of the financial markets. Company management will host a live audio webcast at <span class=\"xn-chron\">4:30 p.m. ET<\/span>\/<span class=\"xn-chron\">9:30 p.m. IST<\/span> to discuss second quarter 2021 financial results and provide a business and financial update. \u00a0<\/p>\n<p>\n        <b>Audio webcast\/conference call:<br \/><\/b>U.S. Dial-In Number: +1 855 353 7924<br \/>International Dial-In Number: +1 503 343 6056<br \/>Passcode: 7187077<\/p>\n<p>A replay of the conference call will be available through <span class=\"xn-chron\">August 10, 2021<\/span>. <\/p>\n<p>Replay U.S. Dial-In Number: +1 855 859 2056<br \/>Replay International Dial-In Number: +1 404 537 3406<br \/>Passcode: 7187077<\/p>\n<p>Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3234037-1&amp;h=692581169&amp;u=http%3A%2F%2Fwww.jazzpharmaceuticals.com%2F&amp;a=www.jazzpharmaceuticals.com\" rel=\"nofollow noopener\">www.jazzpharmaceuticals.com<\/a>.\u00a0<\/p>\n<p>\n        <b><br \/>\n          <u>About Jazz Pharmaceuticals<br \/><\/u><br \/>\n        <\/b>Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases \u2013 often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in\u00a0Dublin, Ireland\u00a0and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3234037-1&amp;h=2774213816&amp;u=https%3A%2F%2Fwww.jazzpharma.com%2F&amp;a=www.jazzpharma.com\" rel=\"nofollow noopener\">www.jazzpharma.com<\/a> and follow @JazzPharma on Twitter.<\/p>\n<div>\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prntblns\">\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Jazz Pharmaceuticals Contacts:<\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen3\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen3\">\n              \n            <\/td>\n<td class=\"prngen3\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b><br \/>\n                    <i>Investors:<\/i><br \/>\n                  <\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b><br \/>\n                    <i>Media:<\/i><br \/>\n                  <\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Andrea N. Flynn, Ph.D.<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Jacqueline Kirby<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Vice President, Head, Investor Relations<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Vice President, Corporate Affairs &amp; Government Relations<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Jazz Pharmaceuticals plc<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Jazz Pharmaceuticals plc<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:investorinfo@jazzpharma.com\" class=\"prnews_a\" rel=\"nofollow noopener\">investorinfo@jazzpharma.com<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:CorporateAffairsMediaInfo@jazzpharma.com\" class=\"prnews_a\" rel=\"nofollow noopener\">CorporateAffairsMediaInfo@jazzpharma.com<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Ireland, +353 1 634 3211<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Ireland, +353 1 697 2141<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">U.S., +1 650 496 2717<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">U.S., +1 215 867 4910<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder9349\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_Logo.jpg\" title=\"Jazz Pharmaceuticals Logo (PRNewsFoto\/Jazz Pharmaceuticals plc) (PRNewsFoto\/Jazz Pharmaceuticals plc)\" alt=\"Jazz Pharmaceuticals Logo (PRNewsFoto\/Jazz Pharmaceuticals plc) (PRNewsFoto\/Jazz Pharmaceuticals plc)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=SF49329&amp;sd=2021-07-20\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021-301337769.html\">https:\/\/www.prnewswire.com\/news-releases\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021-301337769.html<\/a><\/p>\n<p>SOURCE  Jazz Pharmaceuticals plc<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF49329&amp;Transmission_Id=202107201615PR_NEWS_USPR_____SF49329&amp;DateId=20210720\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire DUBLIN, July 20, 2021 \/PRNewswire\/ &#8212;\u00a0Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 second quarter financial results on Tuesday, August 3, 2021 after the close of the financial markets. Company management will host a live audio webcast at 4:30 p.m. ET\/9:30 p.m. IST to discuss second quarter 2021 financial results and provide a business and financial update. \u00a0 Audio webcast\/conference call:U.S. Dial-In Number: +1 855 353 7924International Dial-In Number: +1 503 343 6056Passcode: 7187077 A replay of the conference call will be available through August 10, 2021. Replay U.S. Dial-In Number: +1 855 859 2056Replay International Dial-In Number: +1 404 537 3406Passcode: 7187077 Interested parties may access the live audio webcast via the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-515333","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire DUBLIN, July 20, 2021 \/PRNewswire\/ &#8212;\u00a0Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 second quarter financial results on Tuesday, August 3, 2021 after the close of the financial markets. Company management will host a live audio webcast at 4:30 p.m. ET\/9:30 p.m. IST to discuss second quarter 2021 financial results and provide a business and financial update. \u00a0 Audio webcast\/conference call:U.S. Dial-In Number: +1 855 353 7924International Dial-In Number: +1 503 343 6056Passcode: 7187077 A replay of the conference call will be available through August 10, 2021. Replay U.S. Dial-In Number: +1 855 859 2056Replay International Dial-In Number: +1 404 537 3406Passcode: 7187077 Interested parties may access the live audio webcast via the &hellip; Continue reading &quot;Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-20T20:18:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021\",\"datePublished\":\"2021-07-20T20:18:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/\"},\"wordCount\":305,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/272253\\\/Jazz_Pharmaceuticals_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/\",\"name\":\"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/272253\\\/Jazz_Pharmaceuticals_Logo.jpg\",\"datePublished\":\"2021-07-20T20:18:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/272253\\\/Jazz_Pharmaceuticals_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/272253\\\/Jazz_Pharmaceuticals_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/","og_locale":"en_US","og_type":"article","og_title":"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021 - Market Newsdesk","og_description":"PR Newswire DUBLIN, July 20, 2021 \/PRNewswire\/ &#8212;\u00a0Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 second quarter financial results on Tuesday, August 3, 2021 after the close of the financial markets. Company management will host a live audio webcast at 4:30 p.m. ET\/9:30 p.m. IST to discuss second quarter 2021 financial results and provide a business and financial update. \u00a0 Audio webcast\/conference call:U.S. Dial-In Number: +1 855 353 7924International Dial-In Number: +1 503 343 6056Passcode: 7187077 A replay of the conference call will be available through August 10, 2021. Replay U.S. Dial-In Number: +1 855 859 2056Replay International Dial-In Number: +1 404 537 3406Passcode: 7187077 Interested parties may access the live audio webcast via the &hellip; Continue reading \"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-20T20:18:45+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021","datePublished":"2021-07-20T20:18:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/"},"wordCount":305,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/","name":"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_Logo.jpg","datePublished":"2021-07-20T20:18:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/272253\/Jazz_Pharmaceuticals_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=515333"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515333\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=515333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=515333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=515333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}